Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Identification of fast and slow decliners in Alzheimer disease: a different approach.

Brooks JO 3rd, Yesavage JA.

Alzheimer Dis Assoc Disord. 1995;9 Suppl 1:S19-25. Review.

PMID:
7546595
2.

Is early-onset Alzheimer disease a distinct subgroup within the Alzheimer disease population?

Raskind MA, Carta A, Bravi D.

Alzheimer Dis Assoc Disord. 1995;9 Suppl 1:S2-6. Review.

PMID:
7546596
3.

Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community.

Carcaillon L, Pérès K, Péré JJ, Helmer C, Orgogozo JM, Dartigues JF.

Dement Geriatr Cogn Disord. 2007;23(6):439-45. Epub 2007 Apr 26.

4.

A comment on age at onset as a subtype of Alzheimer disease.

Brooks JO 3rd.

Alzheimer Dis Assoc Disord. 1995;9 Suppl 1:S28-9. Review.

PMID:
7546598
5.

Identification of Alzheimer disease risk by functional magnetic resonance imaging.

Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW.

Arch Neurol. 2005 Dec;62(12):1881-8.

PMID:
16344346
6.

A method for estimating progression rates in Alzheimer disease.

Doody RS, Massman P, Dunn JK.

Arch Neurol. 2001 Mar;58(3):449-54.

PMID:
11255449
7.

Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population.

Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR.

Arch Neurol. 1996 Oct;53(10):1056-61.

PMID:
8859068
8.

Molecular and cell biological aspects of Alzheimer disease.

Shastry BS.

J Hum Genet. 2001;46(11):609-18. Review.

PMID:
11721879
9.

Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.

Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V, Yuan W, Bird TD.

Arch Neurol. 2006 Sep;63(9):1307-11.

PMID:
16966510
10.
11.

Clinical subtypes of Alzheimer's disease.

Petersen RC.

Dement Geriatr Cogn Disord. 1998;9 Suppl 3:16-24. Review.

PMID:
9853198
12.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
13.

Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.

Farlow MR, Hake A, Messina J, Hartman R, Veach J, Anand R.

Arch Neurol. 2001 Mar;58(3):417-22.

PMID:
11255445
14.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
15.

Clinical applications of cognitive event-related potentials in Alzheimer's disease.

Olichney JM, Hillert DG.

Phys Med Rehabil Clin N Am. 2004 Feb;15(1):205-33. Review.

PMID:
15029906
16.

The methodology of studying decline in Alzheimer's disease.

Brooks JO 3rd, Kraemer HC, Tanke ED, Yesavage JA.

J Am Geriatr Soc. 1993 Jun;41(6):623-8.

PMID:
8505459
17.

VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.

Kinkingnéhun S, Sarazin M, Lehéricy S, Guichart-Gomez E, Hergueta T, Dubois B.

Neurology. 2008 Jun 3;70(23):2201-11. doi: 10.1212/01.wnl.0000303960.01039.43. Epub 2008 Apr 30.

PMID:
18448872
18.

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K.

Arch Neurol. 1999 Jun;56(6):673-80.

PMID:
10369305
19.

[Heterogeneity of Alzheimer's disease].

Scheltens P, Vermersch P, Leys D.

Rev Neurol (Paris). 1993;149(1):14-25. Review. French.

PMID:
8337557
20.

Early-onset Alzheimer's disease is associated with greater pathologic burden.

Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL.

J Geriatr Psychiatry Neurol. 2007 Mar;20(1):29-33.

PMID:
17341768

Supplemental Content

Support Center